Evidence map›Paper›PMID 41254992›Full record

ArticleSmall (Weinheim an der Bergstrasse, Germany)2026

SERSµDrop: A Platform to Study Cell-Cell Communication via SERS Imaging.

Paula Piñeiro, Judith Langer, Joaquin Seras-Franzoso, Dorleta Jimenez de Aberasturi, Sara Abalde-Cela, Malou Henriksen-Lacey, Luis M Liz-Marzán

Abstract read
In one paragraph

Article in Small (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. SERSµDrop: A Platform to Study Cell-Cell Communication via SERS Imaging.Small (Weinheim an der Bergstrasse, Germany) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Paula PiñeiroCIC biomaGUNE, Basque Research and Technology Alliance (BRTA), Donostia-San Sebastián, 20014, Spain.ORCID https://orcid.org/0000-0002-0708-8186
Judith LangerCIC biomaGUNE, Basque Research and Technology Alliance (BRTA), Donostia-San Sebastián, 20014, Spain.ORCID https://orcid.org/0000-0003-3527-5728
Joaquin Seras-FranzosoClinical Biochemistry, Drug Delivery & Therapy (CB-DDT), Vall d'Hebron Institute of Research (VHIR), Barcelona, 08035, Spain.ORCID https://orcid.org/0000-0002-7893-4773
Dorleta Jimenez de AberasturiCIC biomaGUNE, Basque Research and Technology Alliance (BRTA), Donostia-San Sebastián, 20014, Spain.ORCID https://orcid.org/0000-0001-5009-3557
Sara Abalde-CelaInternational Iberian Nanotechnology Laboratory (INL), Braga, 4715-330, Portugal.ORCID https://orcid.org/0000-0001-5615-594X
Malou Henriksen-LaceyCIC biomaGUNE, Basque Research and Technology Alliance (BRTA), Donostia-San Sebastián, 20014, Spain.ORCID https://orcid.org/0000-0003-3544-5846
Luis M Liz-MarzánCIC biomaGUNE, Basque Research and Technology Alliance (BRTA), Donostia-San Sebastián, 20014, Spain.ORCID https://orcid.org/0000-0002-6647-1353

Funding

European Commission UKRI #10063360European Commission: EIC Pathfinder Open #101099066J.S.-F. acknowledges funding from Instituto de Salud Carlos III #PI22/01301Ministerio de Universidades FPU20/05789Spanish Ministerio de Ciencia, Innovación y Universidades PID2023-151281OB-I00Spanish Ministerio de Universidades. S.A.-C #101099066
6 · The paper itself

Abstract

Cell-cell communication is a fundamental aspect of cellular physiology, with implications in early cancer detection, tumor progression, metastasis, and therapeutic resistance. One key mechanism driving intercellular communication involves extracellular vesicles (EVs), which facilitate the transfer of proteins, lipids, and nucleic acids between cells and play a critical role in modulating tumor behavior. Current tools to study EV-mediated communication lack the required spatial and temporal resolution to track EV exchange at single-cell level in physiologically relevant environments. This work introduces SERSµDrop, a microfluidic droplet-based platform integrating surface-enhanced Raman spectroscopy (SERS) for high-resolution monitoring of intercellular communication. In this work we co-encapsulate MCF-7 breast cancer cells and human dermal fibroblasts (HDF) in microdroplets and label them with gold nanostars (AuNSt) functionalized with distinct Raman reporters and surface coatings: poly-L-arginine hydrochloride (AuNSt@PA) for HDFs, and anti-CD81 antibodies (AuNSt@AB) to track small EV release from MCF-7 cells. SERS mapping reveals directional transfer of AuNSt@AB-tagged EVs from MCF-7 to HDFs over 4 days, while AuNSt@PA remains intracellular, confirming their limited exocytic behavior. The platform ensures high cell viability, preserves microdroplet integrity, supports high-throughput screening, and enables multiplexed detection, while minimizing SERS signal dilution through spatial confinement.

Indexed as

Cell CommunicationSpectrum Analysis, RamanExtracellular VesiclesFibroblastsGoldHumansMCF-7 CellsMetal NanoparticlesGoldcell encapsulationexocytosisextracellular vesiclesmicrodropletsSERS imagingSERS tags

Identifiers

PMID41254992
PMCPMC12757990

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.